In vivo oxidative damage in rats is associated with barbiturate response but not other cytochrome P450 inducers

Molecular Pharmacology

Volumn 72, Issue 6, 2007, Pages 1419-1424

  Dostalek, Miroslav ^a   Brooks, Joshua D ^a   Hardy, Klarissa D ^a   Milne, Ginger L ^a   Moore, Megan M ^a   Sharma, Sameer ^a   Morrow, Jason D ^a   Guengerich, F Peter ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 AMINOBENZOTRIAZOLE; 16ALPHA CYANOPREGNENOLONE; AROCLOR 1254; BARBITURIC ACID DERIVATIVE; BETA NAPHTHOFLAVONE; BIOLOGICAL MARKER; CLOFIBRATE; CYTOCHROME P450; CYTOCHROME P450 1A; CYTOCHROME P450 2B; CYTOCHROME P450 2E1; CYTOCHROME P450 3A; CYTOCHROME P450 4A; HYDROGEN PEROXIDE; ISONIAZID; ISOPROSTANE DERIVATIVE; MALONALDEHYDE; PHENOBARBITAL; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; ENZYME INDUCTION; ENZYME REPRESSION; IMMUNOBLOTTING; IN VITRO STUDY; IN VIVO STUDY; LIVER; MALE; NONHUMAN; OXIDATION; OXIDATIVE STRESS; PLASMA; PRIORITY JOURNAL; RAT; SPECTROSCOPY; SPRAGUE DAWLEY RAT;

ANIMALS; BARBITURATES; CYTOCHROME P-450 ENZYME SYSTEM; ENZYME INDUCTION; MALE; OXIDATIVE STRESS; PHENOBARBITAL; RATS; RATS, SPRAGUE-DAWLEY;

EID: 36348977578     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.107.040238     Document Type: Article

References (43)

1. Bai J and Cederbaum AI (2006) Adenovirus-mediated expression of CYP2E1 produces liver toxicity in mice. Toxicol Sci 91:365-371.
2. Belanger PM, Lalande M, Dore FM, and Labrecque G (1989) Temporal variations in the pharmacokinetics of isoniazid and N-acetylisoniazid in rats. Drug Metab Dispos 17:91-97.
3. Blättler SM, Rencurel F, Kaufmann MR, and Meyer UA (2007) In the regulation of cytochrome P450 genes, phenobarbital targets LKB1 for necessary activation of AMP-activated protein kinase. Proc Natl Acad Sci U S A 104:1045-1050.
4. Caro AA and Cederbaum AI (2004) Oxidative stress, toxicology, and pharmacology of CYP2E1. Annu Rev Pharmacol Toxicol 44:27-42.
5. Dalton TP, Puga A, and Shertzer HG (2002) Induction of cellular oxidative stress by aryl hydrocarbon receptor activation. Chem Biol Interact 141:77-95.
6. Dupont I, Bodenez P, Berthou F, Simon B, Bardou LG, and Lucas D (2000) Cytochrome P-450 2E1 activity and oxidative stress in alcoholic patients. Alcohol Alcohol 35:98-103.
7. Ekström G and Ingelman-Sundberg M (1989) Rat liver microsomal NADPH-supported oxidase activity and lipid peroxidation dependent on ethanol-inducible cytochrome P-450 (P-450IIE1). Biochem Pharmacol 38:1313-1319.
8. Ekström G, von Bahr C, and Ingelman-Sundberg M (1989) Human liver microsomal cytochrome P-450IIE1. Immunological evaluation of its contribution to microsomal ethanol oxidation, carbon tetrachloride reduction and NADPH oxidase activity. Biochem Pharmacol 38:689-693.
9. Elrick MM, Kramer JA, Alden CL, Blomme EA, Bunch RT, Cabonce MA, Curtiss SW, Kier LD, Kolaja KL, Rodi CP, et al. (2005) Differential display in rat livers treated for 13 weeks with phenobarbital implicates a role for metabolic and oxidative stress in nongenotoxic carcinogenicity. Toxicol Pathol 33:118-126.
10. Ernster L and Nordenbrand K (1967) Microsomal lipid peroxidation. Methods Enzymol 10:574-580.
11. Gillette JR, Brodie BB, and La Du BN (1957) The oxidation of drugs by liver microsomes: on the role of TPNH and oxygen. J Pharmacol Exp Ther 119:532-540.
12. Guengerich FP (2001) Analysis and characterization of enzymes and nucleic acids, in Principles and Methods of Toxicology (Hayes AW ed) pp 1625-1687, Taylor & Francis, Philadelphia.
13. Guengerich FP, Dannan GA, Wright ST, Martin MV, and Kaminsky LS (1982a) Purification and characterization of liver microsomal cytochromes P-450: electrophoretic, spectral, catalytic, and immunochemical properties and inducibility of eight isozymes isolated from rats treated with phenobarbital or β-naphthoflavone. Biochemistry 21:6019-6030.
14. Guengerich FP, Wang P, and Davidson NK (1982b) Estimation of isozymes of microsomal cytochrome P-450 in rats, rabbits, and humans using immunochemical staining coupled with sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Biochemistry 21:1698-1706.
15. Halliwell B and Gutteridge JM (1990) Role of free radicals and catalytic metal ions in human disease: an overview. Methods Enzymol 186:1-85.
16. Hildebrandt AG, Roots I, Tjoe M, and Heinemeyer G (1978) Hydrogen peroxide in hepatic microsomes. Methods Enzymol 52:342-350.
17. Imaoka S, Osada M, Minamiyama Y, Yukimura T, Toyokuni S, Takemura S, Hiroi T, and Funae Y (2004) Role of phenobarbital-inducible cytochrome P450s as a source of active oxygen species in DNA-oxidation. Cancer Lett 203:117-125.
18. Isayama F, Froh M, Bradford BU, McKim SE, Kadiiska MB, Connor HD, Mason RP, Koop DR, Wheeler MD, and Arteel GE (2003) The CYP inhibitor 1-aminobenzotriazole does not prevent oxidative stress associated with alcohol-induced liver injury in rats and mice. Free Radic Biol Med 35:1568-1581.
19. Kadiiska MB, Gladen BC, Baird DD, Graham LB, Parker CE, Ames BN, Basu S, Fitzgerald GA, Lawson JA, Marnett LJ, et al. (2005) Biomarkers of oxidative stress study III. Effects of the nonsteroidal anti-inflammatory agents indomethacin and meclofenamic acid on measurements of oxidative products of lipids in CCl4 poisoning. Free Radic Biol Med 38:711-718.
20. Kaminsky LS, Kennedy MW, Adams SM, and Guengerich FP (1981) Metabolism of dichlorobiphenyls by highly purified isozymes of rat liver cytochrome P-450. Biochemistry 20:7379-7384.
21. Liu L, Bridges RJ, and Eyer CL (2001) Effect of cytochrome P450 1A induction on oxidative damage in rat brain. Mol Cell Biochem 223:89-94.
22. Meschter CL, Mico BA, Mortillo M, Feldman D, Garland WA, Riley JA, and Kaufman LS (1994) A 13-week toxicologic and pathologic evaluation of prolonged cytochromes P450 inhibition by 1-aminobenzotriazole in male rats. Fundam Appl Toxicol 22:369-381.
23. 2-isoprostanes) in carbon tetrachloride hepatotoxicity. An animal model of lipid peroxidation. J Clin Invest 90:2502-2507.
24. 2-isoprostanes) in smokers: smoking as a cause of oxidative damage. New Engl J Med 332:1198-1203.
25. 2-isoprostanes in biological fluids and tissues as measure of oxidant stress. Methods Enzymol 300:3-12.
26. 2-isoprostanes in vitro and in vivo-effects of oxygen tension and glutathione. Arch Biochem Biophys 353:160-171.
27. Nordblom GD and Coon MJ (1977) Hydrogen peroxide formation and stoichiometry of hydroxylation reactions catalyzed by highly purified liver microsomal cytochrome P-450. Arch Biochem Biophys 180:343-347.
28. Omura T and Sato R (1964) The carbon monoxide-binding pigment of liver microsomes. I. Evidence for its hemoprotein nature. J Biol Chem 239:2370-2378.
29. Ortiz de Montellano PR, and Mathews JM (1981) Autocatalytic alkylation of the cytochrome P-450 prosthetic haem group by 1-aminobenzotriazole. Biochem J 195:761-764.
30. Persson JO, Terelius Y, and Ingelman-Sundberg M (1990) Cytochrome P-450-dependent formation of reactive oxygen radicals: isozyme-specific inhibition of P-450-mediated reduction of oxygen and carbon tetrachloride. Xenobiotica 20:887-900.
31. Peter R, Böcker RG, Beaune PH, Iwasaki M, Guengerich FP, and Yang CS (1990) Hydroxylation of chlorzoxazone as a specific probe for human liver cytochrome P-450 IIE1. Chem Res Toxicol 3:566-573.
32. Phillips AH and Langdon RG (1962) Hepatic triphosphopyridine nucleotide-cytochrome c reductase: isolation, characterization, and kinetic studies. J Biol Chem 237:2652-2660.
33. Robertson G, Leclercq I, and Farrell GC (2001) Nonalcoholic steatosis and steatohepatitis. II. Cytochrome P-450 enzymes and oxidative stress. Am J Physiol Gastrointest Liver Physiol 281:G1135-1139.
34. Shiba D and Shimamoto N (1999) Attenuation of endogenous oxidative stress-induced cell death by cytochrome P450 inhibitors in primary cultures of rat hepatocytes. Free Radic Biol Med 27:1019-1026.
35. Strolin-Benedetti M, Brogin G, Bani M, Oesch F, and Hengstler JG (1999) Association of cytochrome P450 induction with oxidative stress in vivo as evidenced by 3-hydroxylation of salicylate. Xenobiotica 29:1171-1180.
36. Thomas PE, Bandiera S, Maines SL, Ryan DE, and Levin W (1987) Regulation of cytochrome P-450j, a high-affinity N-nitrosodimethylamine demethylase, in rat hepatic microsomes. Biochemistry 26:2280-2289.
37. Tong V, Chang TK, Chen J, and Abbott FS (2003) The effect of valproic acid on hepatic and plasma levels of 15-F2t-isoprostane in rats. Free Radic Biol Med 34:1435-1446.
38. Twaroski TP, O'Brien ML, Larmonier N, Glauert HP, and Robertson LW (2001) Polychlorinated biphenyl-induced effects on metabolic enzymes, AP-1 binding, vitamin E, and oxidative stress in the rat liver. Toxicol Appl Pharmacol 171:85-93.
39. Valko M, Leibfritz D, Moncol J, Cronin MT, Mazur M, and Telser J (2007) Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol 39:44-84.
40. Vyas KP, Shibata T, Highet RJ, Yeh HJ, Thomas PE, Ryan DE, Levin W, and Jerina DM (1983) Metabolism of α-naphthoflavone and β-naphthoflavone by rat liver microsomes and highly purified reconstituted cytochrome P-450 systems. J Biol Chem 258:5649-5659.
41. Yun CH, Kim KH, Calcutt MW, and Guengerich FP (2005) Kinetic analysis of oxidation of coumarins by human cytochrome P450 2A6. J Biol Chem 280:12279-12291.
42. Zand R, Nelson SD, Slattery JT, Thummel KE, Kalhorn TF, Adams SP, and Wright JM (1993) Inhibition and induction of cytochrome P4502E1-catalyzed oxidation by isoniazid in humans. Clin Pharmacol Therapeut 54:142-149.
43. Zangar RC, Davydov DR, and Verma S (2004) Mechanisms that regulate production of reactive oxygen species by cytochrome P450. Toxicol Appl Pharmacol 199:316-331.